Ellen J. Kim, MD

faculty photo
Professor of Dermatology at the Hospital of the University of Pennsylvania
Attending Physician, Abramson Cancer Center, Hospital of the University of Pennsylvania
Faculty Revenue Cycle Oversight Coordinator, Department of Dermatology, Hospital of the University of Pennsylvania
Co-Founder and Attending Physician, Cutaneous Graft-vs-Host Disease Clinic, Department of Dermatology, Hospital of the University of Pennsylvania
Medical Director, Perelman Center for Advanced Medicine Dermatology Clinic, Hospital of the University of Pennsylvania
Director, Penn Cutaneous Lymphoma Program, Department of Dermatology, Hospital of the University of Pennsylvania
Department: Dermatology

Contact information
Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania
Room 721, 7th Floor - South Tower
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-662-2737
Fax: 215-615-4966
Education:
A.B. (East Asian Studies)
Harvard University, 1991.
M.D.
University of Pennsylvania, 1996.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical trials for cutaneous T-cell lymphoma (CTCL)

Description of Clinical Expertise

Cutaneous Lymphomas (T-cell and B-cell) and lymphoproliferative disorders
Graft vs Host Disease
Extracorporeal Photopheresis

Selected Publications

Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone B. : Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 Jul 20:e222749. Epub ahead of print. Notes: doi: 10.1001/jamadermatol.2022.2749.

Himeles JM, Holton J, Samimi S, Vittorio C, Rook AH, Haun P, Villasenor-Park J, Kim EJ. : Paying the Price of Cutaneous T-cell Lymphoma: Recent trends in skin directed and self-administered systemic Cutaneous T-cell Lymphoma treatment costs in the United States. J Am Acad Dermatol Page: S0190-9622(22)02251-4. Epub ahead of print. July 2022 Notes: doi: 10.1016/j.jaad.2022.06.1200.

Weiner DM, Lewis DJ, Spaccarelli NG, Clark RA, Nasta SD, Loren AW, Rook AH, Kim EJ.: Management of Relapsed Cutaneous T-Cell Lymphoma Following Allogeneic Hematopoietic Stem Cell Transplantation: Review with Representative Patient Case. Dermatologic Therapy Page: DOI: 10.1111/dth.15538, April 2022.

Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS.: Usage and safety of topical tacrolimus in patients with mycosis fungoides. Clin Exp Dermatol. Mar 4 2022.

Olsen E, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim Y, Wood G, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papdavid E, Quaglino P, Pittelkow M, Prince H, Sanches J, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J. : Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC Blood Nov 2021.

Geskin LJ, Bagot M, Hodak E, Kim EJ.: Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience. Dermatol Ther (Heidelb). 11(4): 1085-1106, Aug 2021.

Maredia H, Cozzio A, Dummer R, Ramelyte E, Kim EJ, Rozati S.: Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome. JAAD Case Rep. 15: 92-96, Jul 2021.

Rastogi S, Zhou L, Kim EJ: Health disparities in clinical trials for mycosis fungoides/Sezary syndrome: A systematic review. J Invest Dermatol (Society for Investigative Dermatology (SID) 2021 Virtual Meeting Abstract Supplement) 141(5): S74, May 2021.

Kim EJ, Poligone B, Mangold A, DeSimone J, Seminario-Vidal L, Wong HK, Guitart J, Pullion C, Straube RC.: Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study). J Invest Dermatol (Society for Investigative Dermatology 2021 Virtual Meeting Abstract Supplement) 141(5 Suppl S1-148): S73, May 2021.

Lewis DJ, Haun PL, Samimi SS, Vittorio CC, Villasenor-Park J, Barta SK, Landsburg DJ, Svoboda J, Nasta SD, Schuster SJ, Rook AH, Kim EJ: Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome. JAMA Dermatol 157(3): 317-321, Mar 2021.

back to top
Last updated: 01/16/2023
The Trustees of the University of Pennsylvania